Developing a reporting system for the surveillance of HIV drug resistance in Europe

surveillance report-23 May 2019

A pilot project was carried out to investigate the feasibility of HIVDR surveillance in EU/EEA countries and to make recommendations for the design and implementation of a potential future HIVDR surveillance system at the European level.

Influenza virus characterisation, Summary Europe, April 2019

surveillance report-15 May 2019

This is the sixth report for the 2018–19 influenza season. As of week 18/2019, 203 585 influenza detections across the WHO European Region had been reported. Detections were 99% type A viruses, with A(H1N1)pdm09 prevailing over A(H3N2), and 1% type B viruses, with 80 (65%) of 124 ascribed to a lineage being B/Yamagata-lineage.

Poliomyelitis - Annual Epidemiological Report for 2017

surveillance report-13 May 2019

The WHO European Region was declared polio-free in 2002. Neither wild-type nor vaccine-type viruses were notified in the WHO European Region in 2017, but the risk of importation and subsequent transmission remains high in certain countries.

Zoonotic influenza - Annual Epidemiological Report for 2018

surveillance report-3 May 2019

No human cases of avian influenza were reported in the EU/EEA. Only two human A(H7N9) infections were reported from China, a significant decrease compared with 2017. Sporadic human cases of avian influenza A(H5N6) and A(H9N2) were reported from China. In 2018, outbreaks and detections of highly pathogenic avian influenza viruses such as A(H5N1), A(H5N2), AH(H5N5), A(H5N6) or A(H5N8) continued to affect poultry and wild and captured birds worldwide, but on a lower scale than in 2017. Influenza viruses A(H1N2)v and A(H3N2)v of swine origin caused human cases in Australia and the United States.

Influenza virus characterisation, March 2019

surveillance report-24 Apr 2019

This is the fifth report for the 2018–19 influenza season. As of week 14 in 2019, 197 027 influenza detections across the WHO European Region had been reported. Detections were 99.1% type A viruses, with A(H1N1)pdm09 prevailing over A(H3N2), and 0.9% type B viruses, with 72 (67%) of 108 ascribed to a B/Yamagata-lineage.